Chronic Conditions

Ozempic®

starting at $1,374.99

Ozempic® (semaglutide) is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events such as heart attack or stroke in people with both type 2 diabetes and known heart disease. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking a natural hormone that stimulates insulin release, reduces the amount of sugar produced by the liver, and slows down digestion to help with appetite control. Ozempic® may also lead to weight loss, making it a beneficial option for people managing both diabetes and obesity. *This product is not eligible for discount*

A once weekly semaglutide injection used off-label for weight loss in combination with diet and exercise

Dosing begins at 0.25 mg once weekly for 4 weeks then increased to 0.5 mg weekly

Dose titration can be delayed based on tolerance or further increased to a max of 2 mg weekly as needed

Injected at least 30 minutes before the first meal, beverage, and other medications

Must be stored at refrigerated temperatures (2°C to 8°C) or at room temperature for up to 56 days (59°F to 86°F)

1 injectable pen = 4 doses or 30 day supply

Refill

HSA/FSA Eligible

Ozempic®

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Ozempic®

I agree, in the form of a declaration, given under oath and penalty of perjury, that I:

General Information

am 18 years or older and am completing this attestation for myself, doing so voluntarily, and have provided accurate demographic information including, but not limited to my valid name, address, IP address, and location I am visiting this website from, along with accurately reporting my sex assigned at birth, height, and weight.
will only use this service to seek a prescription for myself, will use it as prescribed, and will not provide any prescription medicine I receive to any other person.
understand that this attestation under oath will be reviewed and relied on by a doctor licensed in my state (the “Telehealth Provider”) and that the name of the Telehealth Provider who will be responsible for reviewing my attestation and making a prescribing decision, along with his or her credentials, was available to me and I reviewed it by visiting the Consent to Telehealth page on the TelyRx.com website before completing this attestation.
understand that prescribing medications via telemedicine, as is the case during in-person care, is at the professional discretion of the physician. The indication, appropriateness, and safety considerations for each prescription issued during this telemedicine encounter, and the number of refills, if any, will be evaluated by the Telehealth Provider in accordance with state and federal laws, as well as current standards of practice in your state.
agree a valid physician-patient relationship is being established via this asynchronous telemedicine technology, that the virtual visit may be supplemented by additional questions from the doctor or synchronous methodologies such as video calls should the need arise, and the applicable standard of care is being met by this telehealth methodology.
understand and acknowledge that I am responsible for reviewing the terms and conditions relevant to this telehealth encounter located at: https://telyrx.com/terms-conditions prior to proceeding further with this attestation.

understand and acknowledge that this is telehealth model is a supplemental mode of care for my convenience and the Telehealth Provider is not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with my primary provider.
understand and acknowledge that due to the nature telehealth, the Telehealth Provider is not able to: (1) monitor my ongoing health or lab values for side effects or efficacy, (2) observe how I tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended. I am aware of these limitations and nevertheless assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Provider.
understand and acknowledge that by using TelyRx and providing this attestation to the Telehealth Provider, I have created a patient- doctor relationship, am providing informed consent to use this telemedicine technology, and I am being directed by the Telehealth Provider to consult my primary provider immediately after beginning any treatment prescribed by the Telehealth Provider for follow up or to address any adverse reactions because the patient-doctor relationship created by this telehealth encounter terminates at the end of this virtual visit (and/or receipt of the prescription, if appropriate).
agree that the Telehealth Provider determines, in conjunction with applicable laws, whether or not the condition being diagnosed and/or treated is appropriate for a telemedicine encounter.
understand that TelyRx takes appropriate security measures in conjunction with the use of this telemedicine technology, such as encrypting data, enabling password protection of data files, and/or utilizing other reliable authentication techniques, but recognize there remain potential risks to privacy notwithstanding such measures.
hold TelyRx and the Telehealth Provider harmless clause for information lost due to technical failures and provide my express consent for TelyRx and the Telehealth Provider to transmit patient-identifiable information to associates in order to provide the services sought, if done so consistent with state and federal law, including HIPAA.

Clinical Information About Me Specific To The Drug I Am Requesting

am using this medication as an adjunct to diet and exercise to improve glycemic control
do not have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Have not had a hypersensitivity reaction to semaglutide or any component of the formulation
have been previously prescribed Ozempic® for the management of type 2 diabetes mellitus by an authorized healthcare provider
have my plasma glucose levels monitored regularly to ensure effective glycemic control
am aware of the need to monitor for signs and symptoms of pancreatitis, such as severe abdominal pain that may radiate to the back
understand the importance of monitoring for signs of gallbladder disease, including pain in the upper right abdomen or between the shoulder blades
understand the potential risk for thyroid C-cell tumors and will monitor for symptoms such as a mass in the neck, dysphagia, dyspnea, or persistent hoarseness
understand that Ozempic® may cause gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, especially during dose escalation
understand that Ozempic® may cause acute kidney injury, particularly if experiencing dehydration from gastrointestinal symptoms
understand that Ozempic® may cause diabetic retinopathy complications, especially if there is a history of diabetic retinopathy
understand that there is a potential risk of hypersensitivity reactions, including anaphylaxis and angioedema, and will seek immediate medical attention if symptoms occur
am not taking any other GLP-1 receptor agonists concurrently
am aware that this medication is not a substitute for insulin and should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis

Additional Representations Concerning My Clinical History and Physical Information

am generally in good health apart from the condition(s) I am seeking medicine(s) for and am not in immediate distress.
am not pregnant or breastfeeding.
agree that this attestation accurately discloses my complete medical and medication history in a manner that will allow the prescribing Telehealth Provider to make a valid prescribing decision and therefore agree that all medical information relevant to this telehealth encounter that I would share in an in-person visit or using synchronous technology is encompassed in or covered by the representations contained in this attestation and if afforded the opportunity to provide additional information, I would have no additional relevant information to provide but that the Telehealth Provider nevertheless may ask me follow-up questions or obtain further history, including via video means, if doing so is required for the Telehealth Provider to collect adequate information to make a prescribing decision.

General Information About Prescription Drugs

understand and acknowledge this attestation does not contain an exhaustive list of precautions, risks, side effects, or details about taking this medication. More information can be obtained at www.fda.gov and I accept the risk that taking this medication may cause one or more of the side effects found at www.fda.gov
understand and acknowledge that only major drug interactions are listed in this attestation and interactions have not been reviewed against the other medications, supplements, or herbal products I may be taking unless they were also dispensed by TelyRx
understand and acknowledge that I can find more information regarding the way the medication I am seeking interacts with other drugs at www.drugs.com/drug_interactions.html
understand and acknowledge that I should consult additional resources, the information provided with the prescription, and/or ask my primary healthcare provider if I have additional questions concerning potential interactions, precautions, risks, side effects, or details about taking this medication prior to taking the medication

Pharmacy Information

understand and acknowledge that TelyRx is a licensed pharmacy, does not provide medical care or medical advice, and the independent Telehealth Provider who uses TelyRx.com to provide telehealth services acts separately from and is not employed by TelyRx and should not replace your primary provider.
understand and consent to receiving pertinent patient education information regarding the medication I may be prescribed by via electronic means and receive information about refills, if any, via electronic means.
understand and acknowledge that I am responsible for reviewing the information contained in this attestation thoroughly and contacting the Telehealth Provider or my primary provider if I have additional questions or concerns prior to taking any medicine I may be prescribed using TelyRx.com.

Seek Help in Case of Emergency

understand and acknowledge that neither TelyRx nor the Telehealth Provider can provide me with emergency care or crisis intervention. In the event of an emergency, I understand that I should immediately contact 911 or go to the nearest emergency room.

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Ozempic Medication Description
Ozempic® (semaglutide) is a prescription medication administered once weekly as a subcutaneous injection. It is FDA-approved to help improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in those with type 2 diabetes and existing heart disease. By acting like the natural hormone GLP-1, Ozempic helps the body release insulin when blood sugar is high, decreases glucagon (a hormone that raises blood sugar), and slows digestion. These combined actions help smooth out blood sugar levels after meals and support better long-term control.

In addition to its diabetes indication, Ozempic is sometimes prescribed off-label for weight management. Many patients report reduced appetite and lower food intake while taking the medication, which, along with healthy diet and exercise, can lead to meaningful weight loss. Patients often find the once-weekly injection schedule convenient to fit into their routine.

How to Use
- Typically prescribed as a once-weekly injection given on the same day each week, with or without food.
- Treatment often begins at 0.25 mg once weekly for 4 weeks, then increases to 0.5 mg once weekly.
- If additional blood sugar control is needed, the dose may be increased gradually up to 1 mg or 2 mg once weekly.
- Injections can be given in the abdomen, thigh, or upper arm. Rotate sites with each dose.
- Always use a new needle for each injection.
- Your healthcare provider will determine the exact dosing schedule that is right for you.
Black Box Warning

Ozempic® (semaglutide) carries a boxed warning for the risk of thyroid C-cell tumors. It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in those with multiple endocrine neoplasia syndrome type 2 (MEN 2). Patients should promptly report any symptoms such as a lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath.

Important Notes and Warnings
- Ozempic is not indicated for patients with type 1 diabetes or diabetic ketoacidosis.
- The most common side effects include nausea, vomiting, diarrhea, constipation, or abdominal pain, especially during the first few weeks or after a dose increase. These symptoms often improve with continued use.
- Low blood sugar (hypoglycemia) may occur if Ozempic is used in combination with insulin or sulfonylurea medications.
- Patients who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks with their provider.
- Because Ozempic slows stomach emptying, it may affect how other oral medications are absorbed. Your healthcare provider may give guidance on timing other medicines.
Storage
- Store unused pens in the refrigerator between 36°F to 46°F (2°C to 8°C).
- After the first use, pens may be stored at room temperature between 59°F to 86°F (15°C to 30°C) for up to 56 days.
Ozempic Side Effects

Side effects include injection site reactions, constipation, diarrhea, and stomach pain.
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.